Bispecific antibodies to gamma-delta T cells therapy (Janssen Biotech / Lava Therapeutics)

N/A

Report date: 2022/11/02 15:59:18

Base Information

Drug NameBispecific antibodies to gamma-delta T cells therapy (Janssen Biotech / Lava Therapeutics)
Drug Alias NameBispecific antibodies to gamma delta T cells (Janssen Biotech / Lava Therapeutics)Bispecific antibodies to γδT Cell Therapy (Janssen Biotech / Lava Therapeutics)Bi-specific Gamma-Delta T-cell Engager Therapeutics (Janssen Biotech / Lava Therapeutics)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJanssen Biotech IncLava Therapeutics NV
China Registration ClassN/A

Develop Information

Active CompaniesJanssen Biotech IncLava Therapeutics NV
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A